Hydrothermal deposition of CdS on vertically aligned ZnO nanorods for photoelectrochemical solar cell application

CdS/ZnO nanorods composite nanofilms were successfully synthesized via hydrothermal method on indium doped tin oxide glass substrates. Sequentially deposited CdS formed cauliflower like nanostructures on vertically aligned ZnO nanorods. The morphological, compositional, structural and optical properties of the films were characterized by field emission scanning electron microscopy, energy dispersive X-ray analysis, X-ray diffraction and ultraviolet–visible spectroscopy. Photoelectrochemical conversion efficiencies were evaluated by photocurrent measurements in a mixture of Na2S and Na2SO3 akaline aqueous solution. The amount of deposit, as well as the diameter and crystallinity of the CdS cauliflower were found to increase with growth time. CdS/ZnO nanorods composite exhibited greater photocurrent response than ZnO nanorod arrays. Besides, the composite film with 90 min of growth duration displayed the highest photocurrent density which is nearly four times greater than plain ZnO nanorods under the illumination of halogen light. The result exhibited remarkable photoconversion efficiency (η) of 1.92 %

Increasing cure rates of solid tumors by immune checkpoint inhibitors

Abstract Immunotherapy has become the central pillar of cancer therapy. Immune checkpoint inhibitors (ICIs), a major category of tumor immunotherapy, reactivate preexisting anticancer immunity. Initially, ICIs were approved only for advanced and metastatic cancers in the salvage setting after or concurrent with chemotherapy at a response rate of around 20–30% with a few exceptions. With significant progress over the decade, advances in immunotherapy have led to numerous clinical trials investigating ICIs as neoadjuvant and/or adjuvant therapies for resectable solid tumors. The promising results of these trials have led to the United States Food and Drug Administration (FDA) approvals of ICIs as neoadjuvant or adjuvant therapies for non-small cell lung cancer, melanoma, triple-negative breast cancer, and bladder cancer, and the list continues to grow. This therapy represents a paradigm shift in cancer treatment, as many early-stage cancer patients could be cured with the introduction of immunotherapy in the early stages of cancer. Therefore, this topic became one of the main themes at the 2021 China Cancer Immunotherapy Workshop co-organized by the Chinese American Hematologist and Oncologist Network, the China National Medical Products Administration and the Tsinghua University School of Medicine. This review article summarizes the current landscape of ICI-based immunotherapy, emphasizing the new clinical developments of ICIs as curative neoadjuvant and adjuvant therapies for early-stage disease

The Mechanism of Dephosphorylation of Bis(2,4-dinitrophenyl) Phosphate in Mixed Micelles of Cationic Surfactants and Lauryl Hydroxamic Acid

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Mixed micelles of cetyltrimethylammonum bromide (CTABr) or dodecyltrimethylammonium bromide (DTABr) and the alpha-nucleophile, lauryl hydroxamic acid (LHA) accelerate dephosphorylation of bis(2,4-dinitrophenyl)phosphate (BDNPP) over the pH range 4-10. With a 0.1 mole fraction of LHA in DTABr or CTABr, dephosphorylation of BDNPP is approximately 10(4)-fold faster than its spontaneous hydrolysis, and monoanionic LHA(-) is the reactive species. The results are consistent with a mechanism involving concurrent nucleophilic attack by hydroxamate ion (i) on the aromatic carbon, giving an intermediate that decomposes to undecylamine and 2,4-dinitrophenol, and (ii) at phosphorus, giving an unstable intermediate that Undergoes a Lossen rearrangement yielding a series of derivatives including N,N-dialkylurea, undecylamine, Undecyl isocyanate, and carbamyl hydroxamate742182548260INCT-CatalisePRONEXFAPESCFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES